BioRem (CVE:BRM) Shares Down 2.7% – Should You Sell?

BioRem Inc. (CVE:BRM)’s share price was down 2.7% during mid-day trading on Monday . The stock traded as low as C$2.85 and last traded at C$2.87. Approximately 45,600 shares traded hands during mid-day trading, a decline of 11% from the average daily volume of 51,079 shares. The stock had previously closed at C$2.95.

Analysts Set New Price Targets

Separately, Cormark raised shares of BioRem to a “moderate buy” rating in a research note on Tuesday, December 17th.

BioRem Trading Down 1.4 %

The business has a fifty day simple moving average of C$3.04 and a 200 day simple moving average of C$2.62. The company has a debt-to-equity ratio of 48.97, a quick ratio of 1.08 and a current ratio of 1.57. The stock has a market cap of C$42.70 million, a price-to-earnings ratio of 12.95 and a beta of 0.85.

BioRem (CVE:BRM) last issued its quarterly earnings results on Wednesday, November 6th. The company reported C$0.12 EPS for the quarter. BioRem had a return on equity of 59.68% and a net margin of 11.35%.

Insider Buying and Selling at BioRem

In related news, Director Derek Webb sold 120,000 shares of BioRem stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of C$2.93, for a total transaction of C$351,600.00. Company insiders own 1.90% of the company’s stock.

BioRem Company Profile

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.